Thorax

Article	Citations
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19	563
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort	391
Respiratory follow-up of patients with COVID-19 pneumonia	245
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study	219
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms	217
Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study	201
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis	198
COVID-19: in the footsteps of Ernest Shackleton	140
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease	132
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length	131
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial	130
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations	129
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey	125
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort	117
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection	109
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people	90
BTS Clinical Statement on pulmonary sarcoidosis	87
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19	85
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p	84
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19	82
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era	81
Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS	79
Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review	75
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait	71
Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales	68

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide	68
Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data	65
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study	63
Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study	63
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection	63
Severe organising pneumonia following COVID-19	60
Awake prone positioning in COVID-19	58
Neutrophils in asthma: the good, the bad and the bacteria	57
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)	57
Night shift work is associated with an increased risk of asthma	56
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score	56
Bacterial biofilms predominate in both acute and chronic human lung infections	54
Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases	50
COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations	50
Variation in oral microbiome is associated with future risk of lung cancer among never-smokers	49
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19	49
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study	47
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life	47
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis	47
Applications of artificial intelligence and machine learning in respiratory medicine	46
Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis	45
Shift work is associated with positive COVID-19 status in hospitalised patients	44
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy	43
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)	43
Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study	42
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay	42
Identifying patients at risk of post-discharge complications related to COVID-19 infection	41
Face coverings and mask to minimise droplet dispersion and aerosolisation: a video case study	41
Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia	41
Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation	40
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study	40
Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression	40
Social isolation and loneliness as risk factors for hospital admissions for respiratory disease among older adults	39
Case for continuing community NIV and CPAP during the COVID-19 epidemic	39
Balance impairment in individuals with COPD: a systematic review with meta-analysis	39
Pulmonary rehabilitation at a time of social distancing: prime time for tele-rehabilitation?	38
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis	38
COPD assessment test for the evaluation of COVID-19 symptoms	37
Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study	36
The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting	36
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome	36
Long-term survival following initiation of home non-invasive ventilation: a European study	36
Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems	35
Reliability of methods to estimate the fraction of inspired oxygen in patients with acute respiratory failure breathing through non-rebreather reservoir bag oxygen mask	34
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial	34
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study	33
Role of unfolded proteins in lung disease	32
Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank	32
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease	31
Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis	30

Association between COPD exacerbations and lung function decline during maintenance therapy	30
Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections	30
Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19	30
One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage	29
Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT	29
Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis	29
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures	28
Role of extracellular vesicles in chronic lung disease	28
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial	28
COVID-19 vaccine-related interstitial lung disease: a case study	28
Functional electrical stimulation in-bed cycle ergometry in mechanically ventilated patients: a multicentre randomised controlled trial	28
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis	28
Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis	27
Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation	27
Temperature variability and asthma hospitalisation in Brazil, 2000–2015: a nationwide case-crossover study	27
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease	27
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme	27
Relationship between asthma and severe COVID-19: a national cohort study	26
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments	26
Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1–3	25
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial	25
Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome	25
Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial	25
Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies	25
Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD	25
Cross-sectional and longitudinal associations between urinary zinc and lung function among urban adults in China	25
Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis	25
Frailty after lung transplantation is associated with impaired health-related quality of life and mortality	24
Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007–2010)	24
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis	24
Use of inhaled corticosteroids and risk of acquiringPseudomonas aeruginosain patients with chronic obstructive pulmonary disease	24
COPD-derived fibroblasts secrete higher levels of senescence-associated secretory phenotype proteins	24
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects	24
Ambient air pollution exposure and chronic bronchitis in the Lifelines cohort	24
Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis	24
Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study	23
Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis	23
Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017	23
Short-term association among meteorological variation, outdoor air pollution and acute bronchiolitis in children in a subtropical setting	23
Neural ventilatory drive decline as a predominant mechanism of obstructive sleep apnoea events	23
Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients	23
Epidemiology and prognostic factors of pleural empyema	23
Sputum microbiota in adults with CF associates with response to inhaled tobramycin	23
Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score	23
Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight	23
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol	23
Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data	23
Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults	23
British Thoracic Society Guideline for pleural disease	22
BTS Clinical Statement on air travel for passengers with respiratory disease	22
Impact of chronic use of heat-not-burn cigarettes on oxidative stress, endothelial dysfunction and platelet activation: the SUR-VAPES Chronic Study	22
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study	22
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial	22
Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial	22
Delivering low-dose CT screening for lung cancer: a pragmatic approach	22
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis	22
Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial	21
Serum free testosterone and asthma, asthma hospitalisations and lung function in British adults	21
Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study	21
Low vitamin D and risk of bacterial pneumonias: Mendelian randomisation studies in two population-based cohorts	21
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis	21
Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data	21
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study	21
Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer	20
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients	20
Respiratory exacerbations are associated with muscle loss in current and former smokers	20
Different responses of the oral, nasal and lung microbiomes to cigarette smoke	20
Longitudinal effects of ivacaftor and medicine possession ratio in people with theGly551Aspmutation: a 5-year study	20
Functional electrical stimulation‐assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up	20
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study	20
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	19
Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study	19
‘If not TB, what could it be?’ Chest X-ray findings from the 2016 Kenya Tuberculosis Prevalence Survey	19
Secondhand nicotine vaping at home and respiratory symptoms in young adults	19
Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review	19
Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening	19
Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis	19
Ambient PM2.5exposure and hospital cost and length of hospital stay for respiratory diseases in 11 cities in Shanxi Province, China	19
Effects of Wnt signaling on epithelial to mesenchymal transition in chronic rhinosinusitis with nasal polyp	19
Hormonal contraception and the risk of severe asthma exacerbation: 17-year population-based cohort study	18

Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis	18
Unlocking the secrets of long non-coding RNAs in asthma	18
Small airway determinants of airflow limitation in chronic obstructive pulmonary disease	18
Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts	18
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives	18
MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation	18
Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort	18
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment	18
BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability	17
Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis	17
Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis	17
Greenness may improve lung health in low–moderate but not high air pollution areas: Seven Northeastern Cities’ study	17
Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study	17
Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a-5p in recipient mice	17
Pretreatment of aged mice with retinoic acid supports alveolar regeneration via upregulation of reciprocal PDGFA signalling	17
Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis	17
Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort	17
Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis	16
Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis	16
Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma	16
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy	16
Improved asthma control during the COVID-19 pandemic: are there lessons to be learnt?	16
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)	16
Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis	16
Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?	16
Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study	16
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland	16
Exercise as a substitute for traditional airway clearance in cystic fibrosis: a systematic review	16
Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis	16
Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis	16
Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults	15
Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis	15
Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS	15
Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis	15
Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI	15
Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation	15
Parkin, an E3 ubiquitin ligase, enhances airway mitochondrial DNA release and inflammation	15
Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis	15
Longitudinal changes to quadriceps thickness demonstrate acute sarcopenia following admission to hospital for an exacerbation of chronic respiratory disease	15
Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI	15
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19	15
Use of preclinical models for malignant pleural mesothelioma	15
Associations of CT evaluations of antigravity muscles, emphysema and airway disease with longitudinal outcomes in patients with COPD	15
Preprint servers: a ‘rush to publish’ or ‘just in time delivery’ for science?	15
SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ	15
Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey	15
Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease	15
Tension pneumomediastinum in patients with COVID-19	15
Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study	14
Asthma diagnosis: into the fourth dimension	14
Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis	14
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion	14
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma	14
Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis	14
SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research	14
Ceramide and sphingosine-1 phosphate in COPD lungs	14
Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers	14
Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment	14
COVID-19 and what comes after?	13
Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019	13
Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling	13
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study	13
Selection of eligible participants for screening for lung cancer using primary care data	13
Asthma and all-cause mortality in children and young adults: a population-based study	13
Citizen science in the time of COVID-19	13
Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity	13
Effect modification of greenness on PM2.5associated all-cause mortality in a multidrug-resistant tuberculosis cohort	13
Effect of exposure to fine particulate matter during pregnancy and infancy on paediatric allergic rhinitis	13
Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis	13
Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis	13
ABCA3-related interstitial lung disease beyond infancy	13
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review	13
Lung Screen Uptake Trial: results from a single lung cancer screening round	13
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials	12
Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study	12
Building a home ventilation programme: population, equipment, delivery and cost	12
Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort study	12
Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease	12
Maternal asthma is associated with reduced lung function in male infants in a combined analysis of the BLT and BILD cohorts	12
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia	12
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis	12
TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection	12
Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers	12
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study	12
Grandmaternal smoking, asthma and lung function in the offspring: the Lifelines cohort study	12
RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic	12
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection	12
Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease	12
Risk and impact of chronic cough in obese individuals from the general population	12
Cost-effectiveness of outpatient versus inpatient non-invasive ventilation setup in obesity hypoventilation syndrome: the OPIP trial	12
Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities	12
Associations of ultrafine and fine particles with childhood emergency room visits for respiratory diseases in a megacity	12
Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study	12
Respiratory and allergic outcomes among 5-year-old children exposed to pesticides	12
Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease	12